Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
作者信息
Maiolino Angelo, Crusoé Edvan de Queiroz, Martinez Gracia Aparecida, Braga Walter Moisés Tobias, de Farias Danielle Leão Cordeiro, Bittencourt Rosane Isabel, Neto Jorge Vaz Pinto, Ribeiro Glaciano Nogueira, Bernardo Wanderley Marques, Tristão Luca, Magalhaes Roberto J P, Hungria Vânia Tietsche de Moraes
机构信息
Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil; Instituto Americas de Ensino e Pesquisa, Rio de Janeiro, RJ, Brazil.
Hospital Professor Edgar Santos da Universidade Federal da Bahia (HUPES-UFBA), Salvador, BA, Brazil.
出版信息
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):410-418. doi: 10.1016/j.htct.2022.06.003. Epub 2022 Jul 20.
Abstract
摘要
相似文献
1
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.多发性骨髓瘤治疗的诊断与管理指南：巴西血液学、血液治疗与细胞治疗协会项目指南：巴西医学协会 - 2022年。第一部分。
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):410-418. doi: 10.1016/j.htct.2022.06.003. Epub 2022 Jul 20.
2
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012.多发性骨髓瘤治疗的诊断与管理指南：巴西血液学、血液疗法及细胞治疗协会项目指南：巴西医学协会 - 2012年版
Rev Bras Hematol Hemoter. 2013;35(3):201-17. doi: 10.5581/1516-8484.20130050.
3
Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013.急性早幼粒细胞白血病诊断与治疗指南：巴西血液学、血液疗法与细胞治疗协会指南项目：巴西医学协会 - 2013年
Rev Bras Hematol Hemoter. 2014;36(1):71-92. doi: 10.5581/1516-8484.20140018.
4
Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.儿童和青少年原发性免疫性血小板减少症诊断指南：巴西血液学、血液治疗和细胞治疗协会指南项目：巴西医学协会 - 2012年。
Rev Bras Hematol Hemoter. 2013;35(5):358-65. doi: 10.5581/1516-8484.20130105.
5
Guidelines on the treatment of acute myeloid leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2015.急性髓系白血病治疗指南：巴西血液学、血液疗法和细胞治疗协会：项目指南：巴西医学协会 - 2015年
Rev Bras Hematol Hemoter. 2016 Jan-Feb;38(1):58-74. doi: 10.1016/j.bjhh.2016.01.001. Epub 2016 Feb 5.
6
Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.儿童和青少年原发性免疫性血小板减少症治疗指南：巴西血液学、血液治疗与细胞治疗协会指南项目：巴西医学协会 - 2012年
Rev Bras Hematol Hemoter. 2013;35(6):417-27. doi: 10.5581/1516-8484.20130124.
7
Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018.成人免疫性血小板减少症指南：巴西血液学、血液治疗与细胞治疗协会。项目指南：巴西医学协会 - 2018年。
Hematol Transfus Cell Ther. 2018 Jan-Mar;40(1):50-74. doi: 10.1016/j.htct.2017.11.001. Epub 2018 Feb 17.
8
Guidelines on the treatment of anemia of chronic renal failure using recombinant human erythropoietin: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2014.使用重组人促红细胞生成素治疗慢性肾衰竭贫血的指南：巴西血液学、血液疗法及细胞治疗协会指南项目：巴西医学协会 - 2014年
Rev Bras Hematol Hemoter. 2014 Nov-Dec;36(6):450-3. doi: 10.1016/j.bjhh.2014.09.009. Epub 2014 Oct 1.
9
Guidelines on Beta-thalassemia major - regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira - 2016.重型β地中海贫血定期输血治疗指南：巴西血液学、血液治疗与细胞治疗协会：项目指南：巴西医学协会 - 2016年。
Rev Bras Hematol Hemoter. 2016 Oct-Dec;38(4):341-345. doi: 10.1016/j.bjhh.2016.09.003. Epub 2016 Sep 22.
10
Guidelines on neonatal screening and painful vaso-occlusive crisis in sickle cell disease: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2016.镰状细胞病新生儿筛查与疼痛性血管闭塞危象指南：巴西血液学、血液治疗与细胞治疗协会：项目指南：巴西医学协会 - 2016年
Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):147-57. doi: 10.1016/j.bjhh.2016.04.001. Epub 2016 Apr 8.
本文引用的文献
1
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.自体造血干细胞移植对比硼替佐米-美法仑-泼尼松（联合或不联合硼替佐米-来那度胺-地塞米松巩固治疗）以及来那度胺维持治疗用于新诊断的多发性骨髓瘤（EMN02/HO95）：一项多中心、随机、开放标签的3期研究
Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30.
2
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.达雷妥尤单抗、来那度胺、硼替佐米和地塞米松用于适合移植的新诊断多发性骨髓瘤：GRIFFIN 试验。
Blood. 2020 Aug 20;136(8):936-945. doi: 10.1182/blood.2020005288.
3
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.硼替佐米、来那度胺和地塞米松作为多发性骨髓瘤自体移植前的诱导治疗。
Blood. 2019 Oct 17;134(16):1337-1345. doi: 10.1182/blood.2019000241.
4
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.硼替佐米、沙利度胺和地塞米松联合或不联合达雷妥尤单抗用于新诊断多发性骨髓瘤患者自体造血干细胞移植前后（CASSIOPEIA）：一项随机、开放标签、3 期研究。
Lancet. 2019 Jul 6;394(10192):29-38. doi: 10.1016/S0140-6736(19)31240-1. Epub 2019 Jun 3.
5
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.在多发性骨髓瘤自体造血细胞移植前，白消安加美法仑与单用美法仑进行预处理的比较：一项开放标签、随机、3期试验。
Lancet Haematol. 2019 May;6(5):e266-e275. doi: 10.1016/S2352-3026(19)30023-7. Epub 2019 Mar 22.
6
Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma.静脉注射白消安加美法仑与单独使用美法仑作为多发性骨髓瘤患者的预处理方案比较。
Ann Hematol. 2019 Aug;98(8):2013-2015. doi: 10.1007/s00277-019-03663-5. Epub 2019 Mar 16.
7
Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents.新型药物时代≥65岁多发性骨髓瘤患者自体干细胞移植的疗效与安全性
Bone Marrow Transplant. 2019 Oct;54(10):1595-1604. doi: 10.1038/s41409-019-0478-4. Epub 2019 Feb 19.
8
Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study.初治多发性骨髓瘤患者皮下硼替佐米为基础诱导及自体干细胞移植后皮下硼替佐米、沙利度胺和泼尼松巩固的 3 期研究：VCAT 研究。
Leuk Lymphoma. 2019 Sep;60(9):2122-2133. doi: 10.1080/10428194.2019.1579322. Epub 2019 Feb 19.
9
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.自体移植、巩固和维持治疗多发性骨髓瘤：BMT CTN 0702 试验结果。
J Clin Oncol. 2019 Mar 1;37(7):589-597. doi: 10.1200/JCO.18.00685. Epub 2019 Jan 17.
10
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.来那度胺维持治疗与观察用于初诊多发性骨髓瘤患者（Myeloma XI）：一项多中心、开放标签、随机、3 期临床试验。
Lancet Oncol. 2019 Jan;20(1):57-73. doi: 10.1016/S1470-2045(18)30687-9. Epub 2018 Dec 14.
Zotero 插件